Kimberly Gilmour focuses on Immunology, Severe combined immunodeficiency, Hematopoietic stem cell transplantation, Genetic enhancement and Transplantation. His study on Immunology is mostly dedicated to connecting different topics, such as Stem cell. He has included themes like Germline mutation, Antibody and Virology in his Stem cell study.
While the research belongs to areas of Severe combined immunodeficiency, he spends his time largely on the problem of Progenitor cell, intersecting his research to questions surrounding Hematopoietic stem cell, Gene expression, Molecular biology and CD34. His Hematopoietic stem cell transplantation research is multidisciplinary, relying on both Immunodeficiency, Immune dysregulation, Primary immunodeficiency, Severity of illness and Comorbidity. His Transplantation study integrates concerns from other disciplines, such as CD3 and Wiskott–Aldrich syndrome.
Kimberly Gilmour mostly deals with Immunology, Severe combined immunodeficiency, Transplantation, Immunodeficiency and Internal medicine. His work carried out in the field of Immunology brings together such families of science as Mutation, Hematopoietic stem cell transplantation, Stem cell and Genetic enhancement. Kimberly Gilmour has researched Genetic enhancement in several fields, including Progenitor cell, Hematopoietic stem cell and Bone marrow.
His research in Severe combined immunodeficiency intersects with topics in Common gamma chain, Molecular biology and Natural killer cell. The Transplantation study which covers Immunotherapy that intersects with T cell. His study focuses on the intersection of Immune system and fields such as Antigen with connections in the field of X-linked lymphoproliferative disease.
His primary areas of study are Immunology, Primary immunodeficiency, Cancer research, Cohort and Transplantation. Kimberly Gilmour frequently studies issues relating to Haematopoiesis and Immunology. The Haematopoiesis study combines topics in areas such as Progenitor cell, CD34 and Genetic enhancement.
His study on Primary immunodeficiency also encompasses disciplines like
His primary areas of investigation include Immunology, Primary immunodeficiency, Population, Immunodeficiency and Penetrance. His Autoimmunity study, which is part of a larger body of work in Immunology, is frequently linked to CYBB, bridging the gap between disciplines. His Primary immunodeficiency research incorporates themes from Gastroenterology and Hematopoietic stem cell transplantation, Busulfan.
The various areas that he examines in his Immunodeficiency study include Allergy, DiGeorge syndrome, Disease and Pathogenesis. His Penetrance research is multidisciplinary, incorporating elements of Immune dysregulation, Genome, Whole genome sequencing, Genomics and Common variable immunodeficiency. His Antibody titer study in the realm of Antibody connects with subjects such as Adeno-associated virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe;Marc R. Mansour;Kerstin Schwarzwaelder;Cynthia Bartholomae.
Journal of Clinical Investigation (2008)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
H Bobby Gaspar;Kathryn L Parsley;Steven Howe;Doug King.
The Lancet (2004)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim;Hong Zhan;Sujith Samarasinghe;Stuart Adams.
Science Translational Medicine (2017)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick;Carlos A. Guerrero-Bustamante;Rebecca A. Garlena;Daniel A. Russell.
Nature Medicine (2019)
Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
Salima Hacein-Bey Abina;H. Bobby Gaspar;Johanna Blondeau;Laure Caccavelli.
Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
H. Bobby Gaspar;H. Bobby Gaspar;Samantha Cooray;Samantha Cooray;Kimberly C. Gilmour;Kimberly C. Gilmour;Kathryn L. Parsley;Kathryn L. Parsley.
Science Translational Medicine (2011)
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
H. Bobby Gaspar;H. Bobby Gaspar;Emma Bjorkegren;Kate Parsley;Kate Parsley;Kimberly C. Gilmour;Kimberly C. Gilmour.
Molecular Therapy (2006)
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease
Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery.
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.
Yenan T. Bryceson;Daniela Pende;Andrea Maul-Pavicic;Kimberly C. Gilmour.
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Sara Ghorashian;Anne Marijn Kramer;Shimobi Onuoha;Gary Wright.
Nature Medicine (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: